First-ever US FDA-approved Hyaluronic Acid Intradermal Microdroplet Injection approved for improved skin smoothness of the cheeks available to patients at Trifecta Med Spa
Trifecta Med Spa introduces Skinvive by Juvéderm for improved skin smoothness of the cheeks. (Credit: Myriams-Fotos from Pixabay)
Trifecta Med Spa is excited to introduce Allergan Aesthetics SKINVIVE by JUVÉDERM to improve facial skin smoothness of the cheeks in adults over the age of 21.1 SKINVIVE by JUVÉDERM is the first and only intradermal microdroplet injection for skin smoothness treatment available in the US with results lasting through six months with optimal treatment.
Dr. Edward Fruitman- Trifecta Med Spa owner and Medical Director of Trifecta Med Group have said: “We’re excited for the FDA approval announcement for SKINVIVE by JUVÉDERM and can’t wait to offer this to our patients Skin quality is among the top concerns our patients express when seeking aesthetic treatments. SKINVIVE can improve the smoothness of the cheeks leading to skin that looks more hydrated through six months with optimal treatment.”
SKINVIVE by JUVÉDERM is a smooth, injectable hyaluronic acid (HA) gel that contains a small amount of local anesthetic (lidocaine). Unlike other facial injectables that enhance and augment the treatment area, SKINVIVE by JUVÉDERM increases hydration within the skin to improve cheek smoothness. SKINVIVE by JUVÉDERM is a specialized smooth, hydrating gel that flows easily into the skin and is approved for all Fitzpatrick Skin Types I-VI, lightest to darkest, addressing an important unmet need in the category.
The product was designed with global skin health experts to improve skin quality and smoothness of the cheeks leading to a lasting glow. We believe that due to improved skin smoothness, light reflects better off the cheek area, resulting in patients reporting a lasting glow. Treatment is minimally invasive, offers little to no downtime, and provides results over the course of six months without requiring a recurring series of treatments.
Once SKINVIVE by JUVÉDERM is available for treatment, patients can learn about this unique product during their consultation.
The majority of subjects in the clinical study reported experiencing side effects such as redness, lumps/bumps, swelling, bruising, tenderness, pain, firmness, discoloration, and itching at the injection sites, as reported in their 30-day daily diaries. These side effects were usually mild (causing little discomfort and no effect on daily activities) or moderate (causing some discomfort and effect on daily activities) in severity, although a few participants experienced severe side effects (causing great discomfort and effect on daily activities). Investigators also reported needle abrasion and papule at the injection site. While rare, some participants experienced side effects that lasted longer than 30 days; however, most side effects went away on their own within 30 days.
Source: Company Press Release